Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma has disclosed its schedule of upcoming investor meetings in November 2025 as required by SEBI's listing regulations. The company will participate in three conferences in Mumbai: the ICICI Securities India Investor Conference on November 11, the Avendus Spark Annual Investor Conference on November 17, and the JM Financial Investor Conference on November 19. All meetings will be conducted in person through group or one-on-one formats. The company has noted that these dates are subject to change depending on exigencies.
This is a routine regulatory disclosure about investor engagement and does not directly affect the stock price. However, these meetings could be an opportunity for the company to share business updates and outlook with institutional investors, potentially influencing analyst sentiment.